Description
XENGLU-MET 12.5mg + 500mg Tablets 14’s combine Sitagliptin (12.5mg) and Metformin Hydrochloride (500mg) to effectively manage type 2 diabetes mellitus. This combination therapy uses two complementary mechanisms to help control blood sugar levels.
Sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, enhances the body’s natural incretin hormones, increasing insulin secretion and decreasing glucagon release, especially after meals. Metformin reduces glucose production in the liver and improves insulin sensitivity, aiding better glucose utilization by the body.
This formulation is ideal for patients who need improved glycemic control beyond lifestyle changes and monotherapy.
Key Benefits:
-
Dual-action formula to control blood sugar effectively
-
Enhances insulin release and lowers hepatic glucose production
-
Supports better management of type 2 diabetes
-
Convenient oral tablets, usually taken once or twice daily
Usage Instructions: Take as prescribed by your healthcare professional, typically with meals to minimize gastrointestinal discomfort. Do not crush or chew the tablets.
Precautions: Consult your doctor before use if you have kidney or liver conditions. Inform your healthcare provider of all medications to prevent interactions.
Reviews
There are no reviews yet.